Hyperfine (HYPR) Total Current Liabilities (2020 - 2026)
Hyperfine (HYPR) posted Total Current Liabilities of $10.2 million for Q1 2026, down 13.45% on a QoQ basis from $11.7 million in Q4 2025, and up 27.26% year-over-year from $8.0 million in Q1 2025.
Hyperfine (HYPR) Total Current Liabilities (2020 - 2026) Analysis & Trends
Hyperfine's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $10.2 million for Q1 2026.
- Quarterly Total Current Liabilities rose 27.26% year-over-year to $10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.2 million (up 27.26% YoY) and the FY2025 annual result came in at $11.7 million, up 34.4% from the prior year.
- Total Current Liabilities was $10.2 million for Q1 2026 at Hyperfine, down from $11.7 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $12.5 million in Q3 2022 and bottomed at $8.0 million in Q1 2025.
- A 5-year average of $9.4 million and a median of $8.8 million in 2024 frame the typical range for Total Current Liabilities.
- Peak annual rise in Total Current Liabilities reached 9132.54% in 2022, while the deepest fall reached 44.06% in 2022.
- Hyperfine's Total Current Liabilities stood at $8.8 million in 2022, then dropped by 0.4% to $8.8 million in 2023, then declined by 0.44% to $8.7 million in 2024, then jumped by 34.4% to $11.7 million in 2025, then fell by 13.45% to $10.2 million in 2026.
- Business Quant data shows HYPR's Total Current Liabilities at $10.2 million in Q1 2026, $11.7 million in Q4 2025, and $10.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 10.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.15 Mn |
| Dec 31, 2025 | 11.73 Mn |
| Sep 30, 2025 | 10.17 Mn |
| Jun 30, 2025 | 7.99 Mn |
| Mar 31, 2025 | 7.98 Mn |
| Dec 31, 2024 | 8.73 Mn |
| Sep 30, 2024 | 9.96 Mn |
| Jun 30, 2024 | 8.79 Mn |
| Mar 31, 2024 | 8.77 Mn |
| Dec 31, 2023 | 8.77 Mn |
| Sep 30, 2023 | 8.21 Mn |
| Jun 30, 2023 | 8.04 Mn |
| Mar 31, 2023 | 8.00 Mn |
| Dec 31, 2022 | 8.80 Mn |
| Sep 30, 2022 | 12.46 Mn |
| Jun 30, 2022 | 10.46 Mn |
| Mar 31, 2022 | 11.41 Mn |
| Dec 31, 2021 | 15.74 Mn |
| Sep 30, 2021 | 1.95 Mn |
| Jun 30, 2021 | 1.36 Mn |